TrialCancer medicine2024

Chidamide plus R-GDP for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for autologous transplantation: A prospective, single-arm, phase II study.

Guang-Liang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.